Evidence map›Paper›PMID 23415730›Full record

ArticleThe Journal of infection2013

Tuberculosis: time for a new perspective?

Paul T Elkington

Open access · greenAbstract read
In one paragraph

Article in The Journal of infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Permutations of time and place in tuberculosis.The Lancet. Infectious diseases · 2015
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Paul T ElkingtonClinical and Experimental Sciences, University of Southampton, Mailpoint 811, Southampton General Hospital, Southampton SO16 1YD, UK. p.elkington@soton.ac.uk
Southampton General Hospital · GB

Funding

Targeting matrix metalloproteinases to limit immunopathology in airborne infectioR33AI102239 · NIAID · UNIVERSITY OF SOUTHAMPTON · PI ELKINGTON, PAUL TIMOTHY · 2014 to 2016
$1.1M
Targeting matrix metalloproteinases to limit immunopathology in airborne infectioR21AI102239 · NIAID · UNIVERSITY OF SOUTHAMPTON · PI D'ARMIENTO, JEANINE M, ELKINGTON, PAUL TIMOTHY · 2012 to 2013
$289k
Department of Health DHCS/06/05/012Howard Hughes Medical InstituteNIAID NIH HHS (R21 AI102239NIAID NIH HHS R21 AI102239NIAID NIH HHS R33 AI102239
6 · The paper itself

Abstract

Transmission of Mycobacterium tuberculosis (Mtb) continues uninterrupted. Pre-exposure vaccination remains a central focus of tuberculosis research but 25 years of follow up is needed to determine whether a novel childhood vaccination regime protects from adult disease, or like BCG assists Mtb dissemination by preventing childhood illness but not infective adult pulmonary tuberculosis. Therefore, different strategies to interrupt the life cycle of Mtb need to be explored. This personal perspective discusses alternative approaches that may be delivered in a shorter time frame.

Indexed as

BCG VaccineDesmosineHumansLungMycobacterium tuberculosisTuberculosis, PulmonaryVaccinationBCG VaccineDesmosine

Identifiers

PMID23415730
PMCPMC3632295
OpenAlexW2091501922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.